Annandale Capital »

Cullinan Oncology shares owned by Annandale Capital

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by Annandale Capital from 13F filings

Historical chart of Annandale Capital investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by Annandale Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by Annandale Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $122k 12k 10.17
2023-09-30 $109k 12k 9.08
2023-06-30 $108k 10k 10.80
2023-03-31 $102k 10k 10.20
2022-12-31 $106k 10k 10.60
2022-09-30 $128k 10k 12.80